Methotrexate (NSC-740) in squamous cell carcinoma of the head and neck. II. Intermittent intravenous therapy.
D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D006801:Humans; D007822:Laryngeal Neoplasms / Q000188:drug therapy*; D008297:Male; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use*; D010610:Pharyngeal Neoplasms / Q000188:drug therapy*; D014062:Tongue Neoplasms / Q000188:drug therapy*
D008727:Methotrexate